Joel Scanlon

Joel Scanlon

Digital Specialist and Founder of News-Medical.Net

Joel relocated to Australia in 1995 from the United Kingdom and spent five years working in the mining industry as an exploration geotechnician. His role involved utilizing GIS mapping and CAD software. Upon transitioning to the North Coast of NSW, Australia, Joel embarked on a career as a graphic designer at a well-known consultancy firm. Subsequently, he established a successful web services business catering to companies across the eastern seaboard of Australia. It was during this time that he conceived and launched News-Medical.Net. Joel has been an integral part of AZoNetwork since its inception in 2000. Joel possesses a keen interest in exploring the boundaries of technology, comprehending its potential impact on society, and actively engaging with AI-driven solutions and advancements.

Articles from Joel

Analysts Predict $8 Billion Profit for Rio Tinto

China Steel Production Falls, Trial of Iron Ore Index Soon

Rio Tinto to Challenge High Court Ruling on Pilbara Workplace Agreements

Yanzhou Coal Acquires Two Queensland Coal Companies

India's NMDC Looks to Make Foreign Acquistions

Canaco Resources Reports New Assay Results from Magambazi Gold Discovery

Iron Road Provides Details on Stage VI Drilling at Central Eyre Iron Project

Brenham Oil + Gas Buys Oil Field in Abilene, Texas

Black Raven Energy Buys 80% Operating Interest in Adena Field, Colorado

Lundin Petroleum Applies Field Development Plan for Brynhild Field

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.